MedPath

NEW DAY DIAGNOSTICS

๐Ÿ‡ณ๐Ÿ‡ฌNigeria
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:1
Completed:1

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)โ€ข Click on a phase to view related trials

Not Applicable
1 (100.0%)

COVID-19 iCura SARS-CoV-2 Ag OTC: Clinical Evaluation

Not Applicable
Completed
Conditions
SARS-CoV-2 Infection
COVID-19
First Posted Date
2022-09-26
Last Posted Date
2023-02-15
Lead Sponsor
New Day Diagnostics
Target Recruit Count
100
Registration Number
NCT05555030
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Paragon, Anaheim, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

EDP Biotech, Knoxville, Tennessee, United States

CRC Detection Reliable Assessment With Blood

Active, not recruiting
Conditions
Adenomas Colon
Rectal Diseases
Colon Cancer
Rectal Polyp
Colon Neoplasm
Colon Polyp
Gastrointestinal Neoplasms
Colonic Diseases, Functional
Intestinal Disease
Colorectal Cancer
First Posted Date
2022-09-22
Last Posted Date
2025-05-29
Lead Sponsor
New Day Diagnostics
Target Recruit Count
196
Registration Number
NCT05551052
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Gastro SB, Chula Vista, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

SDG Clinical Research, San Diego, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Medical Associates Research Group, San Diego, California, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.